These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 19535880)

  • 1. [Candidemia in an intensive care unit].
    Adukauskiene D; Kinderyte A; Dambrauskiene A; Vitkauskiene A
    Medicina (Kaunas); 2009; 45(5):351-6. PubMed ID: 19535880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia.
    Benjamin DK; Ross K; McKinney RE; Benjamin DK; Auten R; Fisher RG
    Pediatrics; 2000 Oct; 106(4):712-8. PubMed ID: 11015513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species.
    Cheng MF; Yang YL; Yao TJ; Lin CY; Liu JS; Tang RB; Yu KW; Fan YH; Hsieh KS; Ho M; Lo HJ
    BMC Infect Dis; 2005 Apr; 5():22. PubMed ID: 15813977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society.
    Yamamura DL; Rotstein C; Nicolle LE; Ioannou S
    CMAJ; 1999 Feb; 160(4):493-9. PubMed ID: 10081465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
    Playford EG; Marriott D; Nguyen Q; Chen S; Ellis D; Slavin M; Sorrell TC
    Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
    Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
    J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiological and microbiological evaluation of nosocomial infections caused by Candida species].
    Erdem F; Tuncer Ertem G; Oral B; Karakoç E; Demiröz AP; Tülek N
    Mikrobiyol Bul; 2012 Oct; 46(4):637-48. PubMed ID: 23188577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethnicity and other possible risk factors for candidemia at 3 tertiary care university hospitals in Hawaii.
    Fujitani S; Ricardo-Dukelow M; Kamiya T; Sullivan L; Low L
    Infect Control Hosp Epidemiol; 2006 Nov; 27(11):1261-3. PubMed ID: 17080389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
    Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
    Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for candidemia with non-albicans Candida spp. in intensive care unit patients with end-stage renal disease on chronic hemodialysis.
    Serefhanoglu K; Timurkaynak F; Can F; Cagir U; Arslan H; Ozdemir FN
    J Formos Med Assoc; 2012 Jun; 111(6):325-32. PubMed ID: 22748623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the morbidity and pathogens of patients with candidemia at the intensive care unit].
    Yin QQ; Zhang YT; Fang Q
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 May; 29(5):464-8. PubMed ID: 18956679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
    Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF
    Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidemia in intensive care unit patients: risk factors for mortality.
    Voss A; le Noble JL; Verduyn Lunel FM; Foudraine NA; Meis JF
    Infection; 1997; 25(1):8-11. PubMed ID: 9039530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection.
    Klevay MJ; Ernst EJ; Hollanbaugh JL; Miller JG; Pfaller MA; Diekema DJ
    Diagn Microbiol Infect Dis; 2008 Mar; 60(3):273-7. PubMed ID: 18024053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007.
    Nace HL; Horn D; Neofytos D
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):289-94. PubMed ID: 19376670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade.
    Parmeland L; Gazon M; Guerin C; Argaud L; Lehot JJ; Bastien O; Allaouchiche B; Michallet M; Picot S; Bienvenu AL;
    Med Mycol; 2013 Jan; 51(1):33-7. PubMed ID: 22680978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome in critically ill patients with candidal fungaemia: Candida albicans vs. Candida glabrata.
    Blot S; Vandewoude K; Hoste E; Poelaert J; Colardyn F
    J Hosp Infect; 2001 Apr; 47(4):308-13. PubMed ID: 11289775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six-Year Retrospective Analysis of Epidemiology, Risk Factors, and Antifungal Susceptibilities of Candidiasis from a Tertiary Care Hospital in South China.
    Bilal H; Zhang D; Shafiq M; Khan MN; Chen C; Khan S; Wang Q; Cai L; Islam R; Hu H; Zeng Y
    Microbiol Spectr; 2023 Aug; 11(4):e0070823. PubMed ID: 37310269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for fluconazole-resistant candidemia.
    Garnacho-Montero J; Díaz-Martín A; García-Cabrera E; Ruiz Pérez de Pipaón M; Hernández-Caballero C; Aznar-Martín J; Cisneros JM; Ortiz-Leyba C
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3149-54. PubMed ID: 20498325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.